2. Logan AG: Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension. Can Med Assoc J 1984; 131: 1053-1057

3. Carruthers SG, Larochelle P, Haynes RB, et al: Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. Can Med Assoc J 1993; 149: 289-293

4. Haynes RB, Lacourciere Y, Rabkin SW, et al: Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. Can Med Assoc J 1993; 149: 409-418

5. Jackson R, Barham P, Bills J, et al: Management of raised blood pressure in New Zealand: a discussion document. BMJ 1993; 307: 107-110

6. Joffres MR, Hamet P, Rabkin SW, et al: Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. Can Med Assoc J 1992; 146: 1997-2005

7. Dawber TR: The Framingham Study. The epidemiology of atherosclerotic disease. Cambridge: Harvard University Press, 1980

8. Society of Actuaries: Build and blood pressure study. Society of Actuaries, Chicago, 1959

9. Nicholls E, Nair C, MacWilliam L, et al: Cardio-vascular Disease in Canada (addendum to cat 82-544), Statistics Canada and Dept. of National Health and Welfare, Ottawa, 1988

10. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827-838

11. Veterans Administration Cooperative Study Group on Antihypertensive Agents: 1. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967; 202: 1028-1034

12. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143-1152

13. Wolff FW, Lindeman RD: Effects of treatment in hypertension: Results of a controlled study. J Chron Dis 1966; 19: 227-240

14. Hypertension-Stroke Co-operative Study Group: Effect of antihypertensive treatment on stroke recurrence. JAMA 1974; 229: 409-418

15. Smith WM: Treatment of mild hypertension. Results of a ten-year intervention trial. U.S. Public Health Service Hospitals Cooperative Study Group. Circulation 1977; 40 (suppl 1): 98-105

16. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: III. Influence of age, diastolic pressure and prior cardiovascular disease; further analysis of side-effects. Circulation 1972; 45: 991-1004

17. Report of the Ontario Council of Health: Hypertension 1977, Ontario Council Health, Toronto, 1977

18. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-2571

19. Report by the Management Committee. The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980; 1: 1261-1267

20. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br Med J Clin Res Ed 1985; 291: 97-104

21. Amery A, Birkenhager W, Brixko P, et al: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-1354

22. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-3264

23. Dahlof B, Lindholm LH, Hansson L, et al: Morbidity and mortality in the Swedish trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285

24. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412

25. The Management Committee of the Australian National Blood Pressure Study: Prognostic factors in the treatment of mild hypertension. Circulation 1984; 69: 668-676

26. MacMahon SW, Cutler JA, Furberg CD, et al: The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis 1986; 24(3 suppl 1): 99-118

27. Fletcher AE, Bulpitt CJ, Chase DM, et al: Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension 1992; 19: 499-507

28. The Treatment of Mild Hypertension Research Group: The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991; 151: 1413-1423

29. Lewis EJ, Hunsicker LG, Bain RP, et al: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462

30. National High Blood Pressure Education Program: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993; 153: 154-183

31. Neaton JD, Grimm RH Jr, Prineas RJ, et al: Treatment of mild hypertension study. Final results. JAMA 1993; 270: 713-724

32. Wassertheil-Smoller S, Oberman A, Blaufox D, et al: The trial of antihypertensive interventions and management (TAIM) study. Final results with regard to blood pressure, cardiovascular risk, and quality of life. Am J Hypertens 1992; 5: 37-44

33. Neaton JD, Wentworth D: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152: 56-64

34. Alderman MH, Cushman WC, Hill MN, et al: International round table discussion of national guidelines for the detection, evaluation, and treatment of hypertension. Am J Hypertens 1993; 6: 974-981

35. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee: 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/ International Society of Hypertension meeting. Hypertension 1993; 22: 392-403

36. Sever P, Beevers G, Bulpitt C, et al: Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306: 983-987

37. Whitworth JA, Clarkson D, Dwyer T, et al: The management of hypertension: a consensus statement. Med J Aust 1994 (in press)

38. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 1982; 248: 1465-1477

39. Wilhelmsen L, Berglund G, Elmfeldt D, et al: The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986; 7: 279-288

40. Strandberg TE, Salomaa VV, Naukkarinen VA, et al: Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991; 266: 1225-1229

41. Ogilvie RI, Burgess ED, Cusson JR, et al: Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. Can Med Assoc J 1993; 149: 575-584

42. Dawson KG, McKenzie JK, Ross SA, et al: Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes. Can Med Assoc J 1993; 149: 821-826

43. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services: an Assessment of the Effectiveness of 169 Interventions. Williams & Wilkins, Baltimore, Md, 1989: 23-27